[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_1495 

# __Testing strategy limitations__

## Category to which it belongs

* [The challenges in the field of testing and drug development, including limited capacity, slow processes, and the need for improved detection methods, hamper the identification and control of cases.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_134.md)

## Closest similar item

* [Limited testing capacity](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2681.md)
* [Low testing capacity](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3116.md)
* [Testing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3393.md)
* [Limited testing and treatment capabilities](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2786.md)
* [Insufficient testing capacity](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_740.md)
* [Limited access to testing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2340.md)
* [Limited testing access](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_881.md)
* [Mass testing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_335.md)
* [Lack of testing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_543.md)
* [Limited diagnostic tests](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2567.md)

## Description of the risk

Limitations in COVID-19 testing strategies and capacity

## Is the risk affecting GBN scales

* [Yes](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_1.md)

## Type of the risk

* [Physical](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_0.md)

## Type of impact of the risk (according to ISO37100)

* [Living and working environment](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_1.md)

## Type of purpose of the risk (according to ISO37100)

* [Resilience](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_2.md)

## Mitigations of this risk

* [Expand testing capacity, prioritize testing for high-risk individuals and settings, implement targeted testing strategies](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2029.md)

## Name of the risk

Delayed detection of cases, underestimation of the true number of infections, challenges in contact tracing

## Stakeholders who can mitigate this risk

* [Government](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_73.md)
* [Healthcare providers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_121.md)

## Articles mentionning the risk

* [Effectiveness of non-pharmaceutical public health interventions against COVID-19: A systematic review and meta-analysis](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_19.md)

## People affected by this risk

* [Healthcare workers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_68.md)
* [General population](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_9.md)

## Technologies linked to the risk

* [Mobile testing units](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_782.md)
* [Rapid antigen tests](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_780.md)
* [Testing automation](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_781.md)

## Property: has_RiskType

* [Technological](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_5.md)

